Chargement en cours...
AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients
Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/ https://ncbi.nlm.nih.gov/pubmed/24167368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|